{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T02:32:09Z","timestamp":1788402729992,"version":"build-2803163510"},"reference-count":127,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T00:00:00Z","timestamp":1745366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T00:00:00Z","timestamp":1745366400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s11033-025-10520-4","type":"journal-article","created":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T06:12:18Z","timestamp":1745388738000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Targeting hypoxia-related pathobiology in Alzheimer\u2019s disease: strategies for prevention and treatment"],"prefix":"10.1007","volume":"52","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6061-2012","authenticated-orcid":false,"given":"Veerta","family":"Sharma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reet","family":"Verma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2979-1590","authenticated-orcid":false,"given":"Thakur Gurjeet","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,23]]},"reference":[{"issue":"4","key":"10520_CR1","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1056\/NEJMra0909142","volume":"362","author":"HW Querfurth","year":"2010","unstructured":"Querfurth HW, LaFerla FM (2010) Mechanisms of disease. N Engl J Med 362(4):329\u2013344","journal-title":"N Engl J Med"},{"issue":"11","key":"10520_CR2","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/j.exger.2012.07.006","volume":"47","author":"SC Correia","year":"2012","unstructured":"Correia SC, Santos RX, Cardoso S, Carvalho C, Candeias E, Duarte AI, Pl\u00e1cido AI, Santos MS, Moreira PI (2012) Alzheimer disease as a vascular disorder: where do mitochondria fit? Exp Gerontol 47(11):878\u2013886","journal-title":"Exp Gerontol"},{"issue":"12","key":"10520_CR3","doi-asserted-by":"crossref","first-page":"3724","DOI":"10.3390\/molecules26123724","volume":"26","author":"T Behl","year":"2021","unstructured":"Behl T, Kaur D, Sehgal A, Singh S, Sharma N, Zengin G, Andronie-Cioara FL, Toma MM, Bungau S, Bumbu AG (2021) Role of monoamine oxidase activity in Alzheimer\u2019s disease: an insight into the therapeutic potential of inhibitors. Molecules 26(12):3724","journal-title":"Molecules"},{"issue":"1","key":"10520_CR4","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s13024-019-0333-5","volume":"14","author":"MA DeTure","year":"2019","unstructured":"DeTure MA, Dickson DW (2019) The neuropathological diagnosis of Alzheimer\u2019s disease. Mol Neurodegener 14(1):32","journal-title":"Mol Neurodegener"},{"issue":"7","key":"10520_CR5","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.tcb.2020.04.005","volume":"30","author":"AH Baik","year":"2020","unstructured":"Baik AH, Jain IH (2020) Turning the oxygen dial: balancing the highs and lows. Trends Cell Biol 30(7):516\u2013536","journal-title":"Trends Cell Biol"},{"key":"10520_CR6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13054-020-03448-7","volume":"25","author":"M Singer","year":"2021","unstructured":"Singer M, Young PJ, Laffey JG, Asfar P, Taccone FS, Skrifvars MB, Meyhoff CS, Radermacher P (2021) Dangers of hyperoxia. Crit Care 25:1\u201315","journal-title":"Crit Care"},{"issue":"11","key":"10520_CR7","first-page":"5134","volume":"201","author":"A Cirovic","year":"2023","unstructured":"Cirovic A, Cirovic A, Orisakwe OE, Lima RR (2023) Local and systemic hypoxia as inductors of increased aluminum and iron brain accumulation promoting the onset of Alzheimer\u2019s disease. Biol Trace Elem Res 201(11):5134\u20135142","journal-title":"Biol Trace Elem Res"},{"key":"10520_CR8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12929-019-0592-z","volume":"27","author":"PS Chen","year":"2020","unstructured":"Chen PS, Chiu WT, Hsu PL, Lin SC, Peng IC, Wang CY, Tsai SJ (2020) Pathophysiological implications of hypoxia in human diseases. J Biomed Sci 27:1\u201319","journal-title":"J Biomed Sci"},{"issue":"2","key":"10520_CR9","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.expneurol.2009.07.033","volume":"223","author":"X Zhang","year":"2010","unstructured":"Zhang X, Le W (2010) Pathological role of hypoxia in Alzheimer\u2019s disease. Exp Neurol 223(2):299\u2013303","journal-title":"Exp Neurol"},{"key":"10520_CR10","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/B978-0-12-804075-1.00021-3","volume-title":"Complications in neuroanesthesia","author":"PH Manninen","year":"2016","unstructured":"Manninen PH, Unger ZM (2016) Hypoxia. Complications in neuroanesthesia. Academic Press, Cambridge, pp 169\u2013180"},{"issue":"3","key":"10520_CR11","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/1440-1681.12717","volume":"44","author":"BS Ashok","year":"2017","unstructured":"Ashok BS, Ajith TA, Sivanesan S (2017) Hypoxia-inducible factors as neuroprotective agent in Alzheimer\u2019s disease. Clin Exp Pharmacol Physiol 44(3):327\u2013334","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"2","key":"10520_CR12","doi-asserted-by":"crossref","first-page":"310","DOI":"10.4103\/1673-5374.290898","volume":"16","author":"H Hassan","year":"2021","unstructured":"Hassan H, Chen R (2021) Hypoxia in Alzheimer\u2019s disease: effects of hypoxia inducible factors. Neural Regen Res 16(2):310\u2013311","journal-title":"Neural Regen Res"},{"key":"10520_CR13","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.2147\/NDT.S203103","volume":"15","author":"R Lall","year":"2019","unstructured":"Lall R, Mohammed R, Ojha U (2019) What are the links between hypoxia and Alzheimer\u2019s disease? Neuropsychiatr Dis Treat 15:1343\u20131354","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"5","key":"10520_CR14","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.cmet.2019.09.016","volume":"30","author":"X Zhang","year":"2019","unstructured":"Zhang X, Zhang Y, Wang P, Zhang SY, Dong Y, Guangyi Zeng Y, Yan LS, Qing W, Liu H, Liu B, Kong W, Wang X, Jiang C (2019) Adipocyte hypoxia-inducible factor 2\u03b1 suppresses atherosclerosis by promoting adipose ceramide catabolism. Cell Metab 30(5):937\u2013951","journal-title":"Cell Metab"},{"key":"10520_CR15","doi-asserted-by":"crossref","first-page":"813","DOI":"10.3389\/fnins.2018.00813","volume":"12","author":"JM Gaspar","year":"2018","unstructured":"Gaspar JM, Velloso LA (2018) Hypoxia inducible factor as a central regulator of metabolism\u2013implications for the development of obesity. Front Neurosci 12:813","journal-title":"Front Neurosci"},{"key":"10520_CR16","doi-asserted-by":"crossref","first-page":"111729","DOI":"10.1016\/j.biopha.2021.111729","volume":"140","author":"AK Grewal","year":"2021","unstructured":"Grewal AK, Singh TG, Sharma D, Sharma V, Manjinder Singh M, Rahman H, Najda A, Walasek-Janusz M, Kamel M, Albadrani GM, Akhtar MF, Saleem A, Abdel-Daim MM (2021) Mechanistic insights and perspectives involved in neuroprotective action of quercetin. Biomed Pharmacother 140:111729","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"10520_CR17","doi-asserted-by":"crossref","first-page":"6543","DOI":"10.1038\/s41467-022-33624-y","volume":"13","author":"L Qian","year":"2022","unstructured":"Qian L, Rawashdeh O, Kasas L, Milne MR, Garner N, Sankorrakul K, Marks N, Dean MW, Kim PR, Sharma A, Bellingham MC, Coulson EJ (2022) Cholinergic basal forebrain degeneration due to sleep-disordered breathing exacerbates pathology in a mouse model of Alzheimer\u2019s disease. Nat Commun 13(1):6543","journal-title":"Nat Commun"},{"issue":"4","key":"10520_CR18","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.biopsych.2021.02.973","volume":"91","author":"SF Kazim","year":"2022","unstructured":"Kazim SF, Sharma A, Saroja SR, Seo JH, Larson CS, Ramakrishnan A, Wang M, Blitzer RD, Shen L, Pe\u00f1a CJ, Crary JF, Shimoda LA, Zhang B, Nestler EJ, Pereira AC (2022) Chronic intermittent hypoxia enhances pathological tau seeding, propagation, and accumulation and exacerbates Alzheimer-like memory and synaptic plasticity deficits and molecular signatures. Biol Psychiatry 91(4):346\u2013358","journal-title":"Biol Psychiatry"},{"issue":"10","key":"10520_CR19","doi-asserted-by":"crossref","first-page":"110102","DOI":"10.1016\/j.celrep.2021.110102","volume":"37","author":"J Han","year":"2021","unstructured":"Han J, Hyun J, Park J, Jung S, Yoonseo O, Kim Y, Ryu SH, Kim SH, Jeong EI, Jo DG, Park SH, Jung YK (2021) Aberrant role of pyruvate kinase M2 in the regulation of gamma-secretase and memory deficits in Alzheimer\u2019s disease. Cell Rep 37(10):110102","journal-title":"Cell Rep"},{"issue":"12","key":"10520_CR20","first-page":"7591","volume":"11","author":"B Fang","year":"2019","unstructured":"Fang B, Zhao Q, Ling W, Zhang Y, Ou M (2019) Hypoxia induces HT-22 neuronal cell death via Orai1\/CDK5 pathway-mediated Tau hyperphosphorylation. Am J Transl Res 11(12):7591","journal-title":"Am J Transl Res"},{"key":"10520_CR21","doi-asserted-by":"crossref","first-page":"282","DOI":"10.3389\/fnagi.2017.00282","volume":"9","author":"F Zhang","year":"2017","unstructured":"Zhang F, Zhong R, Li S, Fu Z, Cheng C, Cai H, Le W (2017) Acute hypoxia induced an imbalanced M1\/M2 activation of microglia through NF-\u03baB signaling in Alzheimer\u2019s disease mice and wild-type littermates. Front Aging Neurosci 9:282","journal-title":"Front Aging Neurosci"},{"key":"10520_CR22","doi-asserted-by":"crossref","first-page":"101343","DOI":"10.1016\/j.arr.2021.101343","volume":"68","author":"J Burtscher","year":"2021","unstructured":"Burtscher J, Mallet RT, Burtscher M, Millet GP (2021) Hypoxia and brain aging: neurodegeneration or neuroprotection? Ageing Res Rev 68:101343","journal-title":"Ageing Res Rev"},{"issue":"4","key":"10520_CR23","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/s43587-021-00054-2","volume":"1","author":"R March-Diaz","year":"2021","unstructured":"March-Diaz R, Lara-Ure\u00f1a N, Romero-Molina C, Heras-Garvin A, Luis COS, Alvarez-Vergara MI, Sanchez-Garcia MA, Sanchez-Mejias E, Davila JC, Rosales-Nieves AE, Forja C, Navarro V, Gomez-Arboledas A, Sanchez-Mico MV, Viehweger A, Gerpe A, Hodson EJ, Vizuete M, Bishop T, Serrano-Pozo A, Lopez-Barneo J, Berra E, Gutierrez A, Vitorica J, Pascual A (2021) Hypoxia compromises the mitochondrial metabolism of Alzheimer\u2019s disease microglia via HIF1. Nat Aging 1(4):385\u2013399","journal-title":"Nat Aging"},{"key":"10520_CR24","doi-asserted-by":"crossref","first-page":"570045","DOI":"10.3389\/fnmol.2020.570045","volume":"13","author":"A Michalicova","year":"2020","unstructured":"Michalicova A, Majerova P, Kovac A (2020) Tau protein and its role in blood\u2013brain barrier dysfunction. Front Mol Neurosci 13:570045","journal-title":"Front Mol Neurosci"},{"key":"10520_CR25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12017-009-8104-z","volume":"12","author":"VW Chow","year":"2010","unstructured":"Chow VW, Mattson MP, Wong PC, Gleichmann M (2010) An overview of APP processing enzymes and products. NeuroMol Med 12:1\u201312","journal-title":"NeuroMol Med"},{"issue":"5","key":"10520_CR26","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/nrn.2017.29","volume":"18","author":"UC M\u00fcller","year":"2017","unstructured":"M\u00fcller UC, Deller T, Korte M (2017) Not just amyloid: physiological functions of the amyloid precursor protein family. Nat Rev Neurosci 18(5):281\u2013298","journal-title":"Nat Rev Neurosci"},{"issue":"1","key":"10520_CR27","doi-asserted-by":"crossref","first-page":"311","DOI":"10.3233\/JAD-2010-1221","volume":"19","author":"MP Murphy","year":"2010","unstructured":"Murphy MP, LeVine H III (2010) Alzheimer\u2019s disease and the amyloid-\u03b2 peptide. J Alzheimer\u2019s Dis 19(1):311\u2013323","journal-title":"J Alzheimer\u2019s Dis"},{"issue":"49","key":"10520_CR28","doi-asserted-by":"crossref","first-page":"18727","DOI":"10.1073\/pnas.0606298103","volume":"103","author":"X Sun","year":"2006","unstructured":"Sun X, He G, Qing H, Zhou W, Dobie F, Cai F, Matthias Staufenbiel L, Huang E, Song W (2006) Hypoxia facilitates Alzheimer\u2019s disease pathogenesis by up-regulating BACE1 gene expression. Proc Natl Acad Sci 103(49):18727\u201318732","journal-title":"Proc Natl Acad Sci"},{"issue":"15","key":"10520_CR29","doi-asserted-by":"crossref","first-page":"10873","DOI":"10.1074\/jbc.M608856200","volume":"282","author":"X Zhang","year":"2007","unstructured":"Zhang X, Zhou K, Wang R, Cui J, Lipton SA, Liao FF, Huaxi X, Zhang YW (2007) Hypoxia-inducible factor 1\u03b1 (HIF-1\u03b1)-mediated hypoxia increases BACE1 expression and \u03b2-amyloid generation. J Biolo Chem 282(15):10873\u201310880","journal-title":"J Biolo Chem"},{"issue":"2","key":"10520_CR30","doi-asserted-by":"crossref","first-page":"325","DOI":"10.3233\/JAD-130419","volume":"37","author":"S Shiota","year":"2013","unstructured":"Shiota S, Takekawa H, Matsumoto SE, Takeda K, Nurwidya F, Yoshioka Y, Takahashi F, Hattori N, Tabira T, Mochizuki H, Takahashi K (2013) Chronic intermittent hypoxia\/reoxygenation facilitate amyloid-\u03b2 generation in mice. J Alzheimer\u2019s Dis 37(2):325\u2013333","journal-title":"J Alzheimer\u2019s Dis"},{"issue":"5","key":"10520_CR31","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1172\/JCI82409","volume":"126","author":"X Wei","year":"2016","unstructured":"Wei X, Weissmiller AM, White JA, Fang F, Wang X, Yiwen W, Pearn ML, Zhao X, Sawa M, Chen S, Gunawardena S, Ding J, Mobley WC, Chengbiao W (2016) Amyloid precursor protein\u2013mediated endocytic pathway disruption induces axonal dysfunction and neurodegeneration. J Clin Investig 126(5):1815\u20131833","journal-title":"J Clin Investig"},{"issue":"7","key":"10520_CR32","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/j.neurobiolaging.2007.10.011","volume":"30","author":"L Li","year":"2009","unstructured":"Li L, Zhang X, Yang D, Luo G, Chen S, Le W (2009) Hypoxia increases A\u03b2 generation by altering \u03b2-and \u03b3-cleavage of APP. Neurobiol Aging 30(7):1091\u20131098","journal-title":"Neurobiol Aging"},{"issue":"4","key":"10520_CR33","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.neures.2011.12.010","volume":"72","author":"E Rybnikova","year":"2012","unstructured":"Rybnikova E, Gluschenko T, Galeeva A, Tulkova E, Nalivaeva NN, Makova NZ, Turner AJ, Samoilov M (2012) Differential expression of ADAM15 and ADAM17 metalloproteases in the rat brain after severe hypobaric hypoxia and hypoxic preconditioning. Neurosci Res 72(4):364\u2013373","journal-title":"Neurosci Res"},{"key":"10520_CR34","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1007\/s11064-007-9349-2","volume":"32","author":"L Fisk","year":"2007","unstructured":"Fisk L, Nalivaeva NN, Boyle JP, Peers CS, Turner AJ (2007) Effects of hypoxia and oxidative stress on expression of neprilysin in human neuroblastoma cells and rat cortical neurones and astrocytes. Neurochem Res 32:1741\u20131748","journal-title":"Neurochem Res"},{"issue":"2","key":"10520_CR35","doi-asserted-by":"crossref","first-page":"225","DOI":"10.2174\/156720508783954703","volume":"5","author":"LB Hersh","year":"2008","unstructured":"Hersh LB, Rodgers DW (2008) Neprilysin and amyloid beta peptide degradation. Curr Alzheimer Res 5(2):225\u2013231","journal-title":"Curr Alzheimer Res"},{"issue":"16","key":"10520_CR36","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1089\/ars.2014.5845","volume":"21","author":"CY Wang","year":"2014","unstructured":"Wang CY, Wang ZY, Xie JW, Cai JH, Wang T, Ye X, Wang X, An L (2014) CD36 upregulation mediated by intranasal LV-NRF2 treatment mitigates hypoxia-induced progression of Alzheimer\u2019s-like pathogenesis. Antioxid Redox Signal 21(16):2208\u20132230","journal-title":"Antioxid Redox Signal"},{"issue":"3","key":"10520_CR37","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1111\/jnc.15327","volume":"158","author":"CA Butler","year":"2021","unstructured":"Butler CA, Popescu AS, Kitchener EJ, Allendorf DH, Puigdell\u00edvol M, Brown GC (2021) Microglial phagocytosis of neurons in neurodegeneration, and its regulation. J Neurochem 158(3):621\u2013639","journal-title":"J Neurochem"},{"issue":"18","key":"10520_CR38","doi-asserted-by":"crossref","first-page":"3515","DOI":"10.1111\/bph.14618","volume":"176","author":"S Nizami","year":"2019","unstructured":"Nizami S, Hall-Roberts H, Warrier S, Cowley SA, Di Daniel E (2019) Microglial inflammation and phagocytosis in Alzheimer\u2019s disease: potential therapeutic targets. Br J Pharmacol 176(18):3515\u20133532","journal-title":"Br J Pharmacol"},{"issue":"2","key":"10520_CR39","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1002\/jnr.24419","volume":"98","author":"E Gaband\u00e9-Rodr\u00edguez","year":"2020","unstructured":"Gaband\u00e9-Rodr\u00edguez E, Keane L, Capasso M (2020) Microglial phagocytosis in aging and Alzheimer\u2019s disease. J Neurosci Res 98(2):284\u2013298","journal-title":"J Neurosci Res"},{"key":"10520_CR40","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.neures.2018.06.002","volume":"143","author":"J Shang","year":"2019","unstructured":"Shang J, Yamashita T, Zhai Y, Nakano Y, Morihara R, Li X, Tian F, Liu X, Huang Y, Shi X, Sato K, Takemoto M, Hishikawa N, Ohta Y, Abe K (2019) Acceleration of NLRP3 inflammasome by chronic cerebral hypoperfusion in Alzheimer\u2019s disease model mouse. Neurosci Res 143:61\u201370","journal-title":"Neurosci Res"},{"issue":"9","key":"10520_CR41","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/nrn2194","volume":"8","author":"C Ballatore","year":"2007","unstructured":"Ballatore C, Lee VMY, Trojanowski JQ (2007) Tau-mediated neurodegeneration in Alzheimer\u2019s disease and related disorders. Nat Rev Neurosci 8(9):663\u2013672","journal-title":"Nat Rev Neurosci"},{"issue":"12","key":"10520_CR42","doi-asserted-by":"crossref","first-page":"e29257","DOI":"10.1371\/journal.pone.0029257","volume":"6","author":"M Morris","year":"2011","unstructured":"Morris M, Koyama A, Masliah E, Mucke L (2011) Tau reduction does not prevent motor deficits in two mouse models of Parkinson\u2019s disease. PLoS ONE 6(12):e29257","journal-title":"PLoS ONE"},{"key":"10520_CR43","doi-asserted-by":"crossref","first-page":"204","DOI":"10.3389\/fnagi.2019.00204","volume":"11","author":"P Barbier","year":"2019","unstructured":"Barbier P, Zejneli O, Martinho M, Lasorsa A, Belle V, Smet-Nocca C, Tsvetkov PO, Devred F, Landrieu I (2019) Role of tau as a microtubule-associated protein: structural and functional aspects. Front Aging Neurosci 11:204","journal-title":"Front Aging Neurosci"},{"issue":"11","key":"10520_CR44","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1038\/nm.3700","volume":"20","author":"Z Zhang","year":"2014","unstructured":"Zhang Z, Song M, Liu X, Kang SS, Kwon IS, Duong DM, Seyfried NT, Hu WT, Liu Z, Wang JZ, Cheng L, Sun YE, Shan Ping Y, Levey AI, Ye K (2014) Cleavage of tau by asparagine endopeptidase mediates the neurofibrillary pathology in Alzheimer\u2019s disease. Nat Med 20(11):1254\u20131262","journal-title":"Nat Med"},{"key":"10520_CR45","doi-asserted-by":"publisher","DOI":"10.1523\/ENEURO.0418-20.2020","author":"SF Kazim","year":"2021","unstructured":"Kazim SF, Seo JH, Bianchi R, Larson CS, Sharma A, Wong RKS, Gorbachev KY, Pereira AC (2021) Neuronal network excitability in Alzheimer\u2019s disease: the puzzle of similar versus divergent roles of amyloid \u03b2 and tau. Eneuro. https:\/\/doi.org\/10.1523\/ENEURO.0418-20.2020","journal-title":"Eneuro"},{"issue":"1","key":"10520_CR46","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1460-9568.2006.05226.x","volume":"25","author":"JZ Wang","year":"2007","unstructured":"Wang JZ, Grundke-Iqbal I, Iqbal K (2007) Kinases and phosphatases and tau sites involved in Alzheimer neurofibrillary degeneration. Eur J Neurosci 25(1):59\u201368","journal-title":"Eur J Neurosci"},{"key":"10520_CR47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13041-016-0282-7","volume":"10","author":"S Yagishita","year":"2017","unstructured":"Yagishita S, Suzuki S, Yoshikawa K, Iida K, Hirata A, Suzuki M, Takashima A, Maruyama K, Hirasawa A, Awaji T (2017) Treatment of intermittent hypoxia increases phosphorylated tau in the hippocampus via biological processes common to aging. Mol Brain 10:1\u201314","journal-title":"Mol Brain"},{"issue":"2","key":"10520_CR48","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.febslet.2007.12.035","volume":"582","author":"Y Liu","year":"2008","unstructured":"Liu Y, Liu F, Iqbal K, Grundke-Iqbal I, Gong CX (2008) Decreased glucose transporters correlate to abnormal hyperphosphorylation of tau in Alzheimer disease. FEBS Lett 582(2):359\u2013364","journal-title":"FEBS Lett"},{"issue":"4","key":"10520_CR49","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1089\/dna.2014.2757","volume":"34","author":"SC Correia","year":"2015","unstructured":"Correia SC, Resende R, Moreira PI, Pereira CM (2015) Alzheimer\u2019s disease-related misfolded proteins and dysfunctional organelles on autophagy menu. DNA Cell Biol 34(4):261\u2013273","journal-title":"DNA Cell Biol"},{"issue":"2","key":"10520_CR50","doi-asserted-by":"crossref","first-page":"221","DOI":"10.4161\/auto.5.2.7363","volume":"5","author":"W Balduini","year":"2009","unstructured":"Balduini W, Carloni S, Buonocore G (2009) Autophagy in hypoxia-ischemia induced brain injury: evidences and speculations. Autophagy 5(2):221\u2013223","journal-title":"Autophagy"},{"issue":"5","key":"10520_CR51","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.freeradbiomed.2010.06.004","volume":"49","author":"YW Tzeng","year":"2010","unstructured":"Tzeng YW, Lee LY, Chao PL, Lee HC, Wu RT, Lin AMY (2010) Role of autophagy in protection afforded by hypoxic preconditioning against MPP+-induced neurotoxicity in SH-SY5Y cells. Free Radical Biol Med 49(5):839\u2013846","journal-title":"Free Radical Biol Med"},{"issue":"1","key":"10520_CR52","doi-asserted-by":"crossref","first-page":"3301","DOI":"10.1038\/s41598-018-20162-1","volume":"8","author":"Y Song","year":"2018","unstructured":"Song Y, Du Y, Zou W, Luo Y, Zhang X, Fu J (2018) Involvement of impaired autophagy and mitophagy in Neuro-2a cell damage under hypoxic and\/or high-glucose conditions. Sci Rep 8(1):3301","journal-title":"Sci Rep"},{"key":"10520_CR53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12883-014-0245-5","volume":"15","author":"D Liu","year":"2015","unstructured":"Liu D, Zhang L, Li Z, Zhang X, Yue W, Yang H, Min B, Zhang X, Ma D, Yan L (2015) Thinner changes of the retinal nerve fiber layer in patients with mild cognitive impairment and Alzheimer\u2019s disease. BMC Neurol 15:1\u20135","journal-title":"BMC Neurol"},{"issue":"2","key":"10520_CR54","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1021\/acschemneuro.8b00442","volume":"10","author":"F Zhang","year":"2018","unstructured":"Zhang F, Niu L, Li S, Le W (2018) Pathological impacts of chronic hypoxia on Alzheimer\u2019s disease. ACS Chem Neurosci 10(2):902\u2013909","journal-title":"ACS Chem Neurosci"},{"issue":"3","key":"10520_CR55","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/s41582-020-00435-y","volume":"17","author":"F Leng","year":"2021","unstructured":"Leng F, Edison P (2021) Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here? Nat Rev Neurol 17(3):157\u2013172","journal-title":"Nat Rev Neurol"},{"issue":"9","key":"10520_CR56","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1038\/nm.4397","volume":"23","author":"MW Salter","year":"2017","unstructured":"Salter MW, Stevens B (2017) Microglia emerge as central players in brain disease. Nat Med 23(9):1018\u20131027","journal-title":"Nat Med"},{"key":"10520_CR57","doi-asserted-by":"crossref","first-page":"493","DOI":"10.3389\/fimmu.2020.00493","volume":"11","author":"C Lauro","year":"2020","unstructured":"Lauro C, Limatola C (2020) Metabolic reprograming of microglia in the regulation of the innate inflammatory response. Front Immunol 11:493","journal-title":"Front Immunol"},{"issue":"6","key":"10520_CR58","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1093\/brain\/awy079","volume":"141","author":"L Hamelin","year":"2018","unstructured":"Hamelin L, Lagarde J, Doroth\u00e9e G, Potier MC, Corlier F, Kuhnast B, Caille F, Dubois B, Fillon L, Chupin M, Bottlaender M, Sarazin M (2018) Distinct dynamic profiles of microglial activation are associated with progression of Alzheimer\u2019s disease. Brain 141(6):1855\u20131870","journal-title":"Brain"},{"issue":"9","key":"10520_CR59","first-page":"2740","volume":"141","author":"M Dani","year":"2018","unstructured":"Dani M, Wood M, Mizoguchi R, Fan Z, Walker Z, Morgan R, Hinz R, Biju M, Kuruvilla T, Brooks DJ, Edison P (2018) Microglial activation correlates in vivo with both tau and amyloid in Alzheimer\u2019s disease. Brain 141(9):2740\u20132754","journal-title":"Brain"},{"issue":"1","key":"10520_CR60","doi-asserted-by":"crossref","first-page":"a006189","DOI":"10.1101\/cshperspect.a006189","volume":"1","author":"A Serrano-Pozo","year":"2011","unstructured":"Serrano-Pozo A, Frosch MP, Masliah E, Hyman BT (2011) Neuropathological alterations in Alzheimer disease. Cold Spring Harb Perspect Med 1(1):a006189","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10520_CR61","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s00401-013-1177-7","volume":"126","author":"PL McGeer","year":"2013","unstructured":"McGeer PL, McGeer EG (2013) The amyloid cascade-inflammatory hypothesis of Alzheimer disease: implications for therapy. Acta Neuropathol 126:479\u2013497","journal-title":"Acta Neuropathol"},{"issue":"12","key":"10520_CR62","doi-asserted-by":"crossref","first-page":"e81584","DOI":"10.1371\/journal.pone.0081584","volume":"8","author":"SM Smith","year":"2013","unstructured":"Smith SM, Friedle SA, Watters JJ (2013) Chronic intermittent hypoxia exerts CNS region-specific effects on rat microglial inflammatory and TLR4 gene expression. PLoS ONE 8(12):e81584","journal-title":"PLoS ONE"},{"issue":"10","key":"10520_CR63","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.5665\/sleep.5042","volume":"38","author":"E Sapin","year":"2015","unstructured":"Sapin E, Peyron C, Roche F, Gay N, Carcenac C, Savasta M, Levy P, Dematteis M (2015) Chronic intermittent hypoxia induces chronic low-grade neuroinflammation in the dorsal hippocampus of mice. Sleep 38(10):1537\u20131546","journal-title":"Sleep"},{"key":"10520_CR64","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.abb.2019.05.011","volume":"669","author":"E Butturini","year":"2019","unstructured":"Butturini E, Boriero D, de Prati AC, Mariotto S (2019) STAT1 drives M1 microglia activation and neuroinflammation under hypoxia. Arch Biochem Biophys 669:22\u201330","journal-title":"Arch Biochem Biophys"},{"issue":"7701","key":"10520_CR65","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1038\/s41586-018-0023-4","volume":"556","author":"AC Wendeln","year":"2018","unstructured":"Wendeln AC, Degenhardt K, Kaurani L, Gertig M, Ulas T, Jain G, Wagner J, H\u00e4sler LM, Wild K, Skodras A, Blank T, Staszewski O, Datta M, Centeno TP, Vincenzo Capece M, Islam R, Kerimoglu C, Staufenbiel M, Schultze JL, Beyer M, Prinz M, Jucker M, Fischer A, Neher JJ (2018) Innate immune memory in the brain shapes neurological disease hallmarks. Nature 556(7701):332\u2013338","journal-title":"Nature"},{"issue":"2","key":"10520_CR66","doi-asserted-by":"crossref","first-page":"155014771982604","DOI":"10.1177\/1550147719826048","volume":"15","author":"R Baik","year":"2019","unstructured":"Baik R (2019) Class imbalance learning\u2013driven Alzheimer\u2019s detection using hybrid features. Int J Distrib Sens Netw 15(2):1550147719826048","journal-title":"Int J Distrib Sens Netw"},{"issue":"4","key":"10520_CR67","first-page":"342","volume":"86","author":"DD Wang","year":"2008","unstructured":"Wang DD, Bordey A (2008) The astrocyte odyssey. Prog Neurobiol 86(4):342\u2013367","journal-title":"Prog Neurobiol"},{"key":"10520_CR68","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.pneurobio.2016.01.001","volume":"144","author":"LM Osborn","year":"2016","unstructured":"Osborn LM, Kamphuis W, Wadman WJ, Hol EM (2016) Astrogliosis: an integral player in the pathogenesis of Alzheimer\u2019s disease. Prog Neurobiol 144:121\u2013141","journal-title":"Prog Neurobiol"},{"issue":"3","key":"10520_CR69","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.neurobiolaging.2013.09.035","volume":"35","author":"W Kamphuis","year":"2014","unstructured":"Kamphuis W, Middeldorp J, Kooijman L, Sluijs JA, Kooi EJ, Moeton M, Freriks M, Mizee MR, Hol EM (2014) Glial fibrillary acidic protein isoform expression in plaque related astrogliosis in Alzheimer\u2019s disease. Neurobiol Aging 35(3):492\u2013510","journal-title":"Neurobiol Aging"},{"key":"10520_CR70","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.neuroscience.2015.01.007","volume":"323","author":"JJ Rodr\u00edguez-Arellano","year":"2016","unstructured":"Rodr\u00edguez-Arellano JJ, Parpura V, Zorec R, Verkhratsky A (2016) Astrocytes in physiological aging and Alzheimer\u2019s disease. Neuroscience 323:170\u2013182","journal-title":"Neuroscience"},{"key":"10520_CR71","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.neuroscience.2018.11.040","volume":"398","author":"T Macheda","year":"2019","unstructured":"Macheda T, Roberts K, Lyons DN, Higgins E, Ritter KJ, Lin AL, Alilain WJ, Bachstetter AD (2019) Chronic intermittent hypoxia induces robust astrogliosis in an Alzheimer\u2019s disease-relevant mouse model. Neuroscience 398:55\u201363","journal-title":"Neuroscience"},{"issue":"7","key":"10520_CR72","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1111\/j.1460-9568.2009.06712.x","volume":"29","author":"D Schubert","year":"2009","unstructured":"Schubert D, Soucek T, Blouw B (2009) The induction of HIF-1 reduces astrocyte activation by amyloid beta peptide. Eur J Neurosci 29(7):1323\u20131334","journal-title":"Eur J Neurosci"},{"key":"10520_CR73","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.redox.2015.01.008","volume":"4","author":"A Abderrazak","year":"2015","unstructured":"Abderrazak A, Syrovets T, Couchie D, El Hadri K, Friguet B, Simmet T, Rouis M (2015) NLRP3 inflammasome: from a danger signal sensor to a regulatory node of oxidative stress and inflammatory diseases. Redox Biol 4:296\u2013307","journal-title":"Redox Biol"},{"key":"10520_CR74","doi-asserted-by":"crossref","first-page":"100966","DOI":"10.1016\/j.arr.2019.100966","volume":"56","author":"CF Pereira","year":"2019","unstructured":"Pereira CF, Santos AE, Moreira PI, Pereira AC, Sousa FJ, Cardoso SM, Cruz MT (2019) Is Alzheimer\u2019s disease an inflammasomopathy? Ageing Res Rev 56:100966","journal-title":"Ageing Res Rev"},{"key":"10520_CR75","doi-asserted-by":"publisher","DOI":"10.1007\/s43440-024-00613-5","author":"V Sharma","year":"2024","unstructured":"Sharma V, Sharma P, Singh TG (2024) Mechanistic insights on TLR-4 mediated inflammatory pathway in neurodegenerative diseases. Pharmacol Rep. https:\/\/doi.org\/10.1007\/s43440-024-00613-5","journal-title":"Pharmacol Rep"},{"issue":"2","key":"10520_CR76","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.neurobiolaging.2012.05.009","volume":"34","author":"C Guo","year":"2013","unstructured":"Guo C, Wang T, Zheng W, Shan ZY, Teng WP, Wang ZY (2013) Intranasal deferoxamine reverses iron-induced memory deficits and inhibits amyloidogenic APP processing in a transgenic mouse model of Alzheimer\u2019s disease. Neurobiol Aging 34(2):562\u2013575","journal-title":"Neurobiol Aging"},{"key":"10520_CR77","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s00221-012-3101-0","volume":"219","author":"JM Fine","year":"2012","unstructured":"Fine JM, Baillargeon AM, Renner DB, Hoerster NS, Tokarev J, Colton S, Pelleg A, Andrews A, Sparley KA, Krogh KM, Frey WH, Hanson LR (2012) Intranasal deferoxamine improves performance in radial arm water maze, stabilizes HIF-1\u03b1, and phosphorylates GSK3\u03b2 in P301L tau transgenic mice. Exp Brain Res 219:381\u2013390","journal-title":"Exp Brain Res"},{"key":"10520_CR78","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.jns.2017.07.028","volume":"380","author":"JM Fine","year":"2017","unstructured":"Fine JM, Forsberg AC, Stroebel BM, Faltesek KA, Verden DR, Hamel KA, Raney EB, Crow JM, Haase LR, Knutzen KE, Kaczmarczek KD, Frey WH, Hanson LR (2017) Intranasal deferoxamine affects memory loss, oxidation, and the insulin pathway in the streptozotocin rat model of Alzheimer\u2019s disease. J Neurol Sci 380:164\u2013171","journal-title":"J Neurol Sci"},{"issue":"4","key":"10520_CR79","doi-asserted-by":"crossref","first-page":"300","DOI":"10.2174\/156720510791162403","volume":"7","author":"Y Avramovich-Tirosh","year":"2010","unstructured":"Avramovich-Tirosh Y, Bar-Am O, Amit T, Youdim MBH, Weinreb O (2010) Up-regulation of hypoxia-inducible factor (HIF)-1\u03b1 and HIF-target genes in cortical neurons by the novel multifunctional iron chelator anti-Alzheimer drug, M30. Curr Alzheimer Res 7(4):300\u2013306","journal-title":"Curr Alzheimer Res"},{"issue":"5","key":"10520_CR80","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.mad.2012.03.001","volume":"133","author":"L Kupershmidt","year":"2012","unstructured":"Kupershmidt L, Amit T, Bar-Am O, Youdim MB, Weinreb O (2012) Neuroprotection by the multitarget iron chelator M30 on age-related alterations in mice. Mech Ageing Dev 133(5):267\u2013274","journal-title":"Mech Ageing Dev"},{"issue":"2","key":"10520_CR81","doi-asserted-by":"crossref","first-page":"119","DOI":"10.2174\/1567205010666131212112529","volume":"11","author":"D Mechlovich","year":"2014","unstructured":"Mechlovich D, Amit T, Bar-Am O, Mandel S, Youdim M, Weinreb O (2014) The novel multi-target iron chelator, M30 modulates HIF-1\u03b1-related glycolytic genes and insulin signaling pathway in the frontal cortex of APP\/PS1 Alzheimer\u2019s disease mice. Curr Alzheimer Res 11(2):119\u2013127","journal-title":"Curr Alzheimer Res"},{"key":"10520_CR82","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1007\/s00702-015-1394-4","volume":"122","author":"A Knezovic","year":"2015","unstructured":"Knezovic A, Osmanovic-Barilar J, Curlin M, Hof PR, Simic G, Riederer P, Salkovic-Petrisic M (2015) Staging of cognitive deficits and neuropathological and ultrastructural changes in streptozotocin-induced rat model of Alzheimer\u2019s disease. J Neural Transm 122:577\u2013592","journal-title":"J Neural Transm"},{"issue":"2","key":"10520_CR83","doi-asserted-by":"crossref","first-page":"373","DOI":"10.3233\/JAD-143126","volume":"47","author":"LS Pimentel","year":"2015","unstructured":"Pimentel LS, Allard S, Carmo SD, Weinreb O, Danik M, Hanzel CE, Youdim MB, Claudio Cuello A (2015) The multi-target drug M30 shows pro-cognitive and anti-inflammatory effects in a rat model of Alzheimer\u2019s disease. J Alzheimer\u2019s Dis 47(2):373\u2013383","journal-title":"J Alzheimer\u2019s Dis"},{"issue":"7","key":"10520_CR84","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1021\/acschemneuro.8b00194","volume":"9","author":"D Lei","year":"2018","unstructured":"Lei D, Zhao Z, Cui A, Yijiang Zhu L, Zhang JL, Shi S, Chao F, Han X, Gao W, Song T, Xie L, Wang L, Sun S, Guo R, Ma G (2018) Increased iron deposition on brain quantitative susceptibility mapping correlates with decreased cognitive function in Alzheimer\u2019s disease. ACS Chem Neurosci 9(7):1849\u20131857","journal-title":"ACS Chem Neurosci"},{"issue":"3","key":"10520_CR85","first-page":"143","volume":"1","author":"RK Leak","year":"2018","unstructured":"Leak RK (2018) Conditioning against the pathology of Parkinson\u2019s disease. Cond Med 1(3):143","journal-title":"Cond Med"},{"key":"10520_CR86","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1007\/s11055-010-9320-6","volume":"40","author":"EB Manukhina","year":"2010","unstructured":"Manukhina EB, Goryacheva AV, Barskov IV, Viktorov IV, Guseva AA, Pshennikova MG, Khomenko IP, Mashina SYu, Pokidyshev DA, Malyshev IYu (2010) Prevention of neurodegenerative damage to the brain in rats in experimental Alzheimer\u2019s disease by adaptation to hypoxia. Neurosci Behav Physiol 40:737\u2013743","journal-title":"Neurosci Behav Physiol"},{"issue":"2","key":"10520_CR87","doi-asserted-by":"crossref","first-page":"e01513","DOI":"10.1002\/brb3.1513","volume":"10","author":"SX Meng","year":"2020","unstructured":"Meng SX, Wang B, Li WT (2020) Intermittent hypoxia improves cognition and reduces anxiety-related behavior in APP\/PS1 mice. Brain Behav 10(2):e01513","journal-title":"Brain Behav"},{"issue":"1","key":"10520_CR88","doi-asserted-by":"crossref","first-page":"461","DOI":"10.3390\/ijms22010461","volume":"22","author":"SC Correia","year":"2021","unstructured":"Correia SC, Machado NJ, Alves MG, Oliveira PF, Moreira PI (2021) Intermittent hypoxic conditioning rescues cognition and mitochondrial bioenergetic profile in the triple transgenic mouse model of Alzheimer\u2019s Disease. Int J Mol Sci 22(1):461","journal-title":"Int J Mol Sci"},{"key":"10520_CR89","first-page":"1533","volume":"35","author":"H Wang","year":"2020","unstructured":"Wang H, Shi X, Schenck H, Hall JR, Ross SE, Kline GP, Chen S, Mallet RT, Chen P (2020) Intermittent hypoxia training for treating mild cognitive impairment: a pilot study. Am J Alzheimer\u2019s Dis Other Dementias 35:1533","journal-title":"Am J Alzheimer\u2019s Dis Other Dementias"},{"issue":"9","key":"10520_CR90","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.3390\/biom10091247","volume":"10","author":"I Fischer","year":"2020","unstructured":"Fischer I, Barak B (2020) Molecular and therapeutic aspects of hyperbaric oxygen therapy in neurological conditions. Biomolecules 10(9):1247","journal-title":"Biomolecules"},{"key":"10520_CR91","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.neurobiolaging.2017.10.007","volume":"62","author":"R Shapira","year":"2018","unstructured":"Shapira R, Solomon B, Efrati S, Frenkel D, Ashery U (2018) Hyperbaric oxygen therapy ameliorates pathophysiology of 3xTg-AD mouse model by attenuating neuroinflammation. Neurobiol Aging 62:105\u2013119","journal-title":"Neurobiol Aging"},{"issue":"4","key":"10520_CR92","doi-asserted-by":"crossref","first-page":"181","DOI":"10.4103\/2045-9912.248271","volume":"8","author":"PG Harch","year":"2018","unstructured":"Harch PG, Fogarty EF (2018) Hyperbaric oxygen therapy for Alzheimer\u2019s dementia with positron emission tomography imaging: a case report. Med Gas Res 8(4):181\u2013184","journal-title":"Med Gas Res"},{"issue":"11","key":"10520_CR93","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.4103\/1673-5374.135317","volume":"9","author":"X Chai","year":"2014","unstructured":"Chai X, Kong W, Liu L, Yu W, Zhang Z, Sun Y (2014) A viral vector expressing hypoxia-inducible factor 1 alpha inhibits hippocampal neuronal apoptosis. Neural Regen Res 9(11):1145\u20131153","journal-title":"Neural Regen Res"},{"key":"10520_CR94","doi-asserted-by":"crossref","first-page":"837579","DOI":"10.3389\/ftox.2022.837579","volume":"4","author":"M Nabi","year":"2022","unstructured":"Nabi M, Tabassum N (2022) Role of environmental toxicants on neurodegenerative disorders. Front Toxicol 4:837579","journal-title":"Front Toxicol"},{"key":"10520_CR95","doi-asserted-by":"crossref","first-page":"111257","DOI":"10.1016\/j.fct.2020.111257","volume":"139","author":"V Karri","year":"2020","unstructured":"Karri V, Kumar V (2020) A systems toxicology approach to compare the heavy metal mixtures (Pb, As, MeHg) impact in neurodegenerative diseases. Food Chem Toxicol 139:111257","journal-title":"Food Chem Toxicol"},{"key":"10520_CR96","first-page":"19","volume":"3","author":"A Hardisson","year":"2017","unstructured":"Hardisson A, Revert C, Gonzales-Weler D, Rubio C (2017) Aluminium exposure through the diet. Food Sci Nutr 3:19","journal-title":"Food Sci Nutr"},{"key":"10520_CR97","first-page":"1","volume-title":"Advances in neurotoxicology","author":"AV Skalny","year":"2021","unstructured":"Skalny AV, Aschner M, Jiang Y, Gluhcheva YG, Tizabi Y, Lobinski R, Tinkov AA (2021) Molecular mechanisms of aluminum neurotoxicity: update on adverse effects and therapeutic strategies. Advances in neurotoxicology. Elsevier, Academic Press, pp 1\u201334"},{"issue":"2","key":"10520_CR98","doi-asserted-by":"crossref","first-page":"60","DOI":"10.2478\/intox-2014-0009","volume":"7","author":"M Jaishankar","year":"2014","unstructured":"Jaishankar M, Tseten T, Anbalagan N, Mathew BB, Beeregowda KN (2014) Toxicity, mechanism and health effects of some heavy metals. Interdiscip Toxicol 7(2):60\u201372","journal-title":"Interdiscip Toxicol"},{"key":"10520_CR99","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/j.biopha.2016.07.035","volume":"83","author":"S Maya","year":"2016","unstructured":"Maya S, Prakash T, Madhu KD, Goli D (2016) Multifaceted effects of aluminium in neurodegenerative diseases: a review. Biomed Pharmacother 83:746\u2013754","journal-title":"Biomed Pharmacother"},{"issue":"39","key":"10520_CR100","first-page":"653","volume":"114","author":"K Klotz","year":"2017","unstructured":"Klotz K, Weistenh\u00f6fer W, Neff F, Hartwig A, van Thriel C, Drexler H (2017) The health effects of aluminum exposure. Dtsch Arztebl Int 114(39):653","journal-title":"Dtsch Arztebl Int"},{"key":"10520_CR101","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.marenvres.2012.11.005","volume":"91","author":"D de Lima","year":"2013","unstructured":"de Lima D, Roque GM, de Almeida EA (2013) In vitro and in vivo inhibition of acetylcholinesterase and carboxylesterase by metals in zebrafish (Danio rerio). Mar Environ Res 91:45\u201351","journal-title":"Mar Environ Res"},{"issue":"23","key":"10520_CR102","doi-asserted-by":"crossref","first-page":"16558","DOI":"10.3390\/ijms242316558","volume":"24","author":"MA Arruebarrena","year":"2023","unstructured":"Arruebarrena MA, Hawe CT, Lee YM, Branco RC (2023) Mechanisms of cadmium neurotoxicity. Int J Mol Sci 24(23):16558","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10520_CR103","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1093\/toxsci\/kfu208","volume":"143","author":"A Ashok","year":"2015","unstructured":"Ashok A, Rai NK, Tripathi S, Bandyopadhyay S (2015) Exposure to As-, Cd-, and Pb-mixture induces A\u03b2, amyloidogenic APP processing and cognitive impairments via oxidative stress-dependent neuroinflammation in young rats. Toxicol Sci 143(1):64\u201380","journal-title":"Toxicol Sci"},{"key":"10520_CR104","doi-asserted-by":"crossref","first-page":"110373","DOI":"10.1016\/j.biopha.2020.110373","volume":"129","author":"V Sharma","year":"2020","unstructured":"Sharma V, Kaur A, Singh TG (2020) Counteracting role of nuclear factor erythroid 2-related factor 2 pathway in Alzheimer\u2019s disease. Biomed Pharmacother 129:110373","journal-title":"Biomed Pharmacother"},{"key":"10520_CR105","doi-asserted-by":"publisher","DOI":"10.2174\/0113862073311518240416070410","author":"H Li","year":"2024","unstructured":"Li H, Hua Q, Cheng S, Liu X, Cai Q, Zhang J, Peng T, Li J, Wang C, Chengbang Liang Y, Wang SX, Tan Y (2024) The neuroprotect formula: a preventive approach to AD targeting the HIF-1\/PI3K-AKT signaling pathway evaluated through in vivo, in vitro, and network pharmacology approaches. Comb Chem High Throughput Screen. https:\/\/doi.org\/10.2174\/0113862073311518240416070410","journal-title":"Comb Chem High Throughput Screen"},{"issue":"3","key":"10520_CR106","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1007\/s11011-022-01137-8","volume":"38","author":"RR Zhen","year":"2023","unstructured":"Zhen RR, Yan-Jie Q, Zhang LM, Chao G, Ding MR, Chen L, Peng X, Bing H, An HM (2023) Exploring the potential anti-Alzheimer disease mechanisms of alpiniae oxyphyliae fructus by network pharmacology study and molecular docking. Metab Brain Dis 38(3):933\u2013944","journal-title":"Metab Brain Dis"},{"key":"10520_CR107","first-page":"104","volume":"7","author":"C Guo","year":"2015","unstructured":"Guo C, Zhang YX, Wang T, Zhong ML, Yang ZH, Hao LJ, Chai R, Zhang S (2015) Intranasal deferoxamine attenuates synapse loss via up-regulating the P38\/HIF-1\u03b1 pathway on the brain of APP\/PS1 transgenic mice. Front Aging Neurosci 7:104","journal-title":"Front Aging Neurosci"},{"issue":"1","key":"10520_CR108","doi-asserted-by":"crossref","first-page":"4335","DOI":"10.1038\/s41598-017-04175-w","volume":"7","author":"JY Kim","year":"2017","unstructured":"Kim JY, Lee HJ, Lee SJ, Jung YH, Yoo DY, Hwang IK, Seong JK, Ryu JM, Han HJ (2017) Palmitic acid-BSA enhances Amyloid-\u03b2 production through GPR40-mediated dual pathways in neuronal cells: involvement of the Akt\/mTOR\/HIF-1\u03b1 and Akt\/NF-\u03baB pathways. Sci Rep 7(1):4335","journal-title":"Sci Rep"},{"key":"10520_CR109","doi-asserted-by":"crossref","first-page":"109370","DOI":"10.1016\/j.biopha.2019.109370","volume":"120","author":"Q Zeng","year":"2019","unstructured":"Zeng Q, Li L, Wingsum Siu Y, Jin MC, Li W, Chen J, Cong W, Ma M, Chen K, Zhengzhi W (2019) A combined molecular biology and network pharmacology approach to investigate the multi-target mechanisms of Chaihu Shugan San on Alzheimer\u2019s disease. Biomed Pharmacother 120:109370","journal-title":"Biomed Pharmacother"},{"issue":"7","key":"10520_CR110","doi-asserted-by":"crossref","first-page":"C636","DOI":"10.1152\/ajpcell.00345.2012","volume":"304","author":"B Chhunchha","year":"2013","unstructured":"Chhunchha B, Fatma N, Kubo E, Rai P, Singh SP, Singh DP (2013) Curcumin abates hypoxia-induced oxidative stress based-ER stress-mediated cell death in mouse hippocampal cells (HT22) by controlling Prdx6 and NF-\u03baB regulation. Am J Physiol Cell Physiol 304(7):C636\u2013C655","journal-title":"Am J Physiol Cell Physiol"},{"issue":"12","key":"10520_CR111","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1001\/archneur.60.12.1685","volume":"60","author":"CW Ritchie","year":"2003","unstructured":"Ritchie CW, Bush AI, Mackinnon A, Macfarlane S, Mastwyk M, MacGregor L, Kiers L, Cherny R, Li QX, Tammer A, Carrington D, Mavros C, Volitakis I, Xilinas M, Ames D, Davis S, Beyreuther K, Tanzi RE, Masters CL (2003) Metal-protein attenuation with iodochlorhydroxyquin (clioquinol) targeting A\u03b2 amyloid deposition and toxicity in Alzheimer disease: a pilot phase 2 clinical trial. Arch Neurol 60(12):1685\u20131691","journal-title":"Arch Neurol"},{"issue":"s4","key":"10520_CR112","doi-asserted-by":"crossref","first-page":"S537","DOI":"10.3233\/JAD-141557","volume":"42","author":"P Grammas","year":"2014","unstructured":"Grammas P, Martinez JM (2014) Targeting thrombin: an inflammatory neurotoxin in Alzheimer\u2019s disease. J Alzheimer\u2019s Dis 42(s4):S537\u2013S544","journal-title":"J Alzheimer\u2019s Dis"},{"key":"10520_CR113","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/s12031-011-9644-x","volume":"46","author":"NN Nalivaeva","year":"2012","unstructured":"Nalivaeva NN, Belyaev ND, Lewis DI, Pickles AR, Makova NZ, Bagrova DI, Dubrovskaya NM, Plesneva SA, Zhuravin IA, Turner AJ (2012) Effect of sodium valproate administration on brain neprilysin expression and memory in rats. J Mol Neurosci 46:569\u2013577","journal-title":"J Mol Neurosci"},{"issue":"1","key":"10520_CR114","doi-asserted-by":"crossref","first-page":"297","DOI":"10.3233\/JAD-160329","volume":"54","author":"L Yu","year":"2016","unstructured":"Yu L, Chen Y, Wang W, Xiao Z, Hong Y (2016) Multi-vitamin B supplementation reverses hypoxia-induced tau hyperphosphorylation and improves memory function in adult mice. J Alzheimer\u2019s Dis 54(1):297\u2013306","journal-title":"J Alzheimer\u2019s Dis"},{"issue":"16","key":"10520_CR115","doi-asserted-by":"crossref","first-page":"e37799","DOI":"10.1097\/MD.0000000000037799","volume":"103","author":"Y Chen","year":"2024","unstructured":"Chen Y, Lai M, Tao M (2024) Evaluating the efficacy and safety of Alzheimer\u2019s disease drugs: a meta-analysis and systematic review. Medicine 103(16):e37799","journal-title":"Medicine"},{"key":"10520_CR116","volume-title":"Memantine. In StatPearl","author":"B Kuns","year":"2024","unstructured":"Kuns B, Rosani A, Patel P, Varghese D (2024) Memantine. In StatPearl. StatPearls Publishing, Treasure Island"},{"key":"10520_CR117","first-page":"02048","volume":"23","author":"M Er-rajy","year":"2024","unstructured":"Er-rajy M, Abdalla M, Abuelizz HA, Zarougui S, Alkhulaifi FM, Alahmady NF, Elhallaoui M (2024) In-silico investigations of novel tacrine derivatives potency against Alzheimer\u2019s disease. Sci Afr 23:02048","journal-title":"Sci Afr"},{"issue":"5","key":"10520_CR118","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1177\/1533317513518658","volume":"29","author":"S Lehrer","year":"2014","unstructured":"Lehrer S (2014) Nasal NSAIDs for Alzheimer\u2019s disease. Am J Alzheimer\u2019s Dis Other Dement 29(5):401\u2013403","journal-title":"Am J Alzheimer\u2019s Dis Other Dement"},{"key":"10520_CR119","doi-asserted-by":"crossref","first-page":"102091","DOI":"10.1016\/j.arr.2023.102091","volume":"91","author":"S Khemka","year":"2023","unstructured":"Khemka S, Reddy A, Garcia RI, Jacobs M, Reddy RP, Roghani AK, Pattoor V, Basu T, Ujala Sehar P, Reddy H (2023) Role of diet and exercise in aging, Alzheimer\u2019s disease, and other chronic diseases. Ageing Res Rev 91:102091","journal-title":"Ageing Res Rev"},{"issue":"s1","key":"10520_CR120","doi-asserted-by":"crossref","first-page":"S109","DOI":"10.3233\/JAD-201074","volume":"82","author":"A Merelli","year":"2021","unstructured":"Merelli A, Repetto M, Lazarowski A, Auzmendi J (2021) Hypoxia, oxidative stress, and inflammation: three faces of neurodegenerative diseases. J Alzheimer\u2019s Dis 82(s1):S109\u2013S126","journal-title":"J Alzheimer\u2019s Dis"},{"key":"10520_CR121","doi-asserted-by":"crossref","first-page":"1402774","DOI":"10.3389\/fnagi.2024.1402774","volume":"16","author":"B Tao","year":"2024","unstructured":"Tao B, Gong W, Xu C, Ma Z, Mei J, Chen M (2024) The relationship between hypoxia and Alzheimer\u2019s disease: an updated review. Front Aging Neurosci 16:1402774","journal-title":"Front Aging Neurosci"},{"key":"10520_CR122","doi-asserted-by":"crossref","first-page":"113917","DOI":"10.1016\/j.biopha.2022.113917","volume":"156","author":"B Liang","year":"2022","unstructured":"Liang B, Deng L, Zhou X (2022) Targeting hypoxia-related metabolism molecules: How to improve tumour immune and clinical treatment? Biomed Pharmacother 156:113917","journal-title":"Biomed Pharmacother"},{"issue":"10","key":"10520_CR123","doi-asserted-by":"crossref","first-page":"11149","DOI":"10.1007\/s10462-023-10415-5","volume":"56","author":"S El-Sappagh","year":"2023","unstructured":"El-Sappagh S, Alonso-Moral JM, Abuhmed T, Ali F, Bugar\u00edn-Diz A (2023) Trustworthy artificial intelligence in Alzheimer\u2019s disease: state of the art, opportunities, and challenges. Artif Intell Rev 56(10):11149\u201311296","journal-title":"Artif Intell Rev"},{"key":"10520_CR124","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1007\/978-3-031-35529-5_92","volume-title":"Drug discovery and evaluation: safety and pharmacokinetic assays","author":"KK Mak","year":"2024","unstructured":"Mak KK, Wong YH, Pichika MR (2024) Artificial intelligence in drug discovery and development. In: Hock FJ, Pugsley MK (eds) Drug discovery and evaluation: safety and pharmacokinetic assays. Springer, Cham, pp 1461\u20131498"},{"issue":"2","key":"10520_CR125","first-page":"31","volume":"11","author":"S Lista","year":"2022","unstructured":"Lista S, Santos-Lozano A, Mart\u00edn-Hern\u00e1ndez J, Men\u00e9ndez H, Pinto-Fraga J, Maroto-Izquierdo S, Maisto N, Borg JJ, Emanuele E, Mercuri NB, Lucia A, Nistic\u00f2 R (2022) Towards personalized therapies for Alzheimer\u2019s disease: challenges for translating molecular genetics and systems biology into strategies to prevent complex chronic brain disorders. Eur J Neurodegener Dis 11(2):31\u201341","journal-title":"Eur J Neurodegener Dis"},{"issue":"1","key":"10520_CR126","first-page":"43","volume":"15","author":"M Nasb","year":"2024","unstructured":"Nasb M, Tao W, Chen N (2024) Alzheimer\u2019s disease puzzle: delving into pathogenesis hypotheses. Aging Dis 15(1):43","journal-title":"Aging Dis"},{"issue":"3","key":"10520_CR127","doi-asserted-by":"crossref","first-page":"949","DOI":"10.3233\/JAD-201448","volume":"80","author":"YY Wang","year":"2021","unstructured":"Wang YY, Huang ZT, Yuan MH, Jing F, Cai RL, Zou Q, Yin-Shuang P, Wang SY, Chen F, Yi WM, Zhang HJ, Cai ZY (2021) Role of hypoxia inducible factor-1\u03b1 in Alzheimer\u2019s disease. J Alzheimer\u2019s Dis 80(3):949\u2013961","journal-title":"J Alzheimer\u2019s Dis"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-025-10520-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-025-10520-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-025-10520-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,27]],"date-time":"2025-12-27T16:33:56Z","timestamp":1766853236000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-025-10520-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,23]]},"references-count":127,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["10520"],"URL":"https:\/\/doi.org\/10.1007\/s11033-025-10520-4","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,23]]},"assertion":[{"value":"16 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}],"article-number":"416"}}